Axiomer technology
Axiomer RNA editing technology
- External link RNA Editing Summit (2023) Harnessing chemical modifications to improve ADAR potency and unlock Axiomer broad applicability
- Internal link DATS (2023) Monica Aguila, Exploring the potential of new RNA editing technologies leveraging ADAR endogenous machinery
- Internal link TIDES USA (2023) Gerard Platenburg, Unlocking the Potential of Innovative Editing Oligonucleotides (EONs) to Address Liver Originated Disorders
- Internal link Analyst & Investor Axiomer Technology R&D Event (2023)
- Internal link GRC (2023) Gerard Platenburg, Unlocking the Potential of Innovative Editing Oligonucleotides to Address Liver Originated Disorders
- Internal link OPT Congress (2023) Gerard Platenburg, Therapeutic potential of an RNA editing platform using Editing Oligonucleotides (EONs)
- Internal link TIDES Europe (2022) Gerard Platenburg, Progress on Development of RNA Base Editing Technologies for Precision Medicines
- Internal link TIDES USA (2022) Gerard Platenburg, Development of RNA Base Editing Technologies for Precision Medicines
-
Download link Axiomer Technology Overview pdf, 2.25 MB - Internal link JACS (2021) Erin E. Doherty et al., Rational Design of RNA Editing Guide Strands: Cytidine Analogs at the Orphan Position
- Internal link OTS (2018) Julien Boudet et al., Structure-based computational approach for optimizing oligonucleotides for A-to-I editing
- Internal link TIDES EU (2018) Antti Aalto, Axiomer Technology - Therapeutic oligonucleotides for directing site-specific A-to-I editing by endogenous ADAR enzymes